Compare APPA to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 0.94 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | |
| Prev Close: | 0.93 |
| Open: | 0.93 |
| Bid: | N/A |
| Ask: | 2,000.00 x 100 |
| 1y Target Est: | 2.50 |
| Day's Range: | 0.92 - 0.95 |
|---|---|
| 52wk Range: | 0.30 - 1.21 |
| Volume: | 3,300 |
| Avg Vol (3m): | 56,384.4 |
| Market Cap: | 37.01M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.39 |
| Div & Yield: | N/A (N/A) |
| Tue, Nov 24 | AP PHARMA INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or StandardEDGAR Online |
| Mon, Nov 23 | A.P. Pharma Receives Notice of Compliance with Nasdaq Continued Listing RequirementsBusiness Wire |
| Fri, Nov 20 | AP PHARMA INC /DE/ FinancialsEDGAR Online Financials |
| Mon, Nov 16 | AP PHARMA INC /DE/ Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online |
| Mon, Nov 16 | AP PHARMA INC /DE/ Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Mon, Nov 16 | A.P. Pharma Q3 loss narrows to $1.2Mat bizjournals.com |
| Mon, Nov 16 | A.P. Pharma Reports Third Quarter 2009 Financial ResultsBusiness Wire |
| Wed, Oct 28 | AP PHARMA INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or StandardEDGAR Online |
| Wed, Oct 28 | A.P. Pharma to Transfer to Nasdaq Capital MarketBusiness Wire |
| Thu, Oct 22 | AP PHARMA INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity SecuriEDGAR Online |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.